Non-randomised controlled trial of the Hope programme for people living with long COVID

Are there improvements in mental wellbeing following a digital peer-supported self-management intervention versus a wait-list control group, for people living with long COVID? A non-randomised pre-post study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN11868601

Enrollment

120

Registered

2022-02-18

Start date

2022-01-13

Completion date

Unknown

Last updated

2022-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Supporting people living with long-term symptoms of COVID-19 ('long COVID') Infections and Infestations

Interventions

Current intervention as of 24/08/2022: The Long COVID Hope Programme is an 8-week programme that combines positive psychology and cognitive behavioural approaches and is delivered by t

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Adults aged 18 years and over 2. Self-reported or diagnosed long COVID symptoms 3. UK-based

Exclusion criteria

Exclusion criteria: No access to an internet-enabled device to engage with the intervention

Design outcomes

Primary

Measure	Time frame
Positive mental wellbeing measured using the Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS), at baseline and 8 weeks later	—

Secondary

Measure	Time frame
1. Self-efficacy measured by the Self-Efficacy for Managing Chronic Disease 6 item scale (SEMCD6) at baseline and 8 weeks later 2. Fatigue measured by the Fatigue Severity Scale (FSS), at baseline and 8 weeks later 3. Loneliness measured by the UCLA Loneliness Scale, Version 3 (UCLA3) at baseline and 8 weeks later 4. Depression measured by the Patient Health Questionnaire 9 item scale (PHQ9) at baseline and 8 weeks later 5. Anxiety measured by the Generalised Anxiety Disorder 7 item scale (GAD7) at baseline and 8 weeks later 6. Long COVID symptoms reported via the COVID-19 Yorkshire Rehabilitation Screening Tool (C19-YRS) at baseline and 8 weeks later	—

Measure

Time frame

1. Self-efficacy measured by the Self-Efficacy for Managing Chronic Disease 6 item scale (SEMCD6) at baseline and 8 weeks later 2. Fatigue measured by the Fatigue Severity Scale (FSS), at baseline and 8 weeks later 3. Loneliness measured by the UCLA Loneliness Scale, Version 3 (UCLA3) at baseline and 8 weeks later 4. Depression measured by the Patient Health Questionnaire 9 item scale (PHQ9) at baseline and 8 weeks later 5. Anxiety measured by the Generalised Anxiety Disorder 7 item scale (GAD7) at baseline and 8 weeks later 6. Long COVID symptoms reported via the COVID-19 Yorkshire Rehabilitation Screening Tool (C19-YRS) at baseline and 8 weeks later

—

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026